Ms. Souhir Belloumi | Antibiotics | Best Researcher Award

Published on by Infectious

Ms. Souhir Belloumi | Antibiotics | Best Researcher Award

PhD student at Center of Biotechnology of Borj Cedria,Tunisia

Ms. Souhir Belloumi is a dedicated junior researcher whose work revolves around biological sciences with a significant emphasis on Antibiotics. Her proficiency in medical biotechnology, food preservation, and environmental sciences is reflected in her contributions to Antibiotics innovation and research. She has extensively used Antibiotics knowledge in the assessment of bioactive compounds, emphasizing their roles in microbial inhibition and preservation. Souhir Belloumi’s exposure to diverse laboratory environments provided her with advanced understanding of Antibiotics effects and applications. Her research path is aligned closely with practical implementations of Antibiotics in both food and pharmaceutical contexts. The persistent engagement with Antibiotics studies through international collaborations and peer-reviewed work demonstrates her foundational commitment to this field. Her scientific writing often centers around Antibiotics, exploring novel mechanisms and usage across biological systems. The relevance of Antibiotics in her scientific outputs signifies her awareness of global health challenges. She continuously integrates Antibiotics theory with experimental data to advance sustainable health solutions. Belloumi’s work reflects a conscious focus on Antibiotics resistance, alternatives, and application. Her competence and determination show in how she repeatedly applies Antibiotics-based frameworks for preservation strategies and public health measures. Hence, the trajectory of her work positions Antibiotics at the very core of her professional identity.

Professional Profile

Scopus

Education

Souhir Belloumi's education is built upon a solid foundation in biological sciences, consistently integrating the concept of Antibiotics in her academic endeavors. During her PhD studies at the University of Tunis El-Manar, she worked on projects involving the development of bioactive compounds, where Antibiotics usage and efficacy were regularly assessed. Her two Master's degrees from the University of Carthage expanded her grasp on biomonitoring and environmental systems, with a continual focus on how Antibiotics influence microbial dynamics and environmental health. The integration of Antibiotics in molecular biology research was a recurring theme during her Bachelor's studies at the High Institute of Medical Technologies. Throughout her education, Antibiotics remained central to course projects, lab reports, and literature reviews. Whether examining microbial contamination or studying natural inhibitors, she frequently incorporated Antibiotics perspectives. These academic programs allowed her to explore various dimensions of Antibiotics, such as resistance, effectiveness, and natural alternatives. The intersection of Antibiotics with molecular diagnostics, virology, and ecology shaped much of her lab training. Each stage of her academic progress was marked by increased understanding of Antibiotics mechanisms and applications. This commitment highlights her deep-rooted interest in Antibiotics as a multidisciplinary subject crucial for modern biosciences.

Experience

Souhir Belloumi’s professional journey showcases her long-standing dedication to Antibiotics research, spanning roles in academia and biotech centers. As a Research Scientist at the Laboratory of Bioactive Substances, she led studies exploring natural Antibiotics derived from essential oils, analyzing their efficacy in poultry preservation. She employed Antibiotics-based techniques to evaluate microbial inhibition, developing sustainable methods relevant to the food industry. During her internship at the University of Pisa, she collaborated with global experts on medicinal plants, emphasizing Antibiotics identification using LC-MS/MS. Her work consistently focused on optimizing the application of Antibiotics through analytical tools and biological assays. At the Pasteur Institute of Tunisia, she worked on rabies diagnostics and vaccine development where Antibiotics played a crucial role in bacterial transformations and culture purification. In multiple internships, she investigated viral effects and molecular changes with Antibiotics-based analysis being a critical tool. Her involvement in industrial projects with Poulina Holdings reaffirmed her skill in applying Antibiotics to real-world scenarios. These diverse experiences demonstrate her hands-on capability with Antibiotics and her ability to adapt them in varied biological contexts. Through continuous application, testing, and assessment, Antibiotics has remained the cornerstone of her professional impact and contribution to science.

Research Interest

Souhir Belloumi’s research interest is deeply rooted in the investigation and application of Antibiotics across various biological systems. Her focus areas include food preservation, molecular diagnostics, and environmental biotechnology, all unified through the lens of Antibiotics use and impact. She is particularly intrigued by natural alternatives to synthetic Antibiotics and actively studies the bioactivity of essential oils as potential candidates. Her interest extends to the mechanisms of microbial resistance, where Antibiotics play a central role in her comparative and functional analyses. She engages in research on the molecular pathways affected by Antibiotics and investigates how resistance develops in response to environmental exposure. The role of Antibiotics in virology, especially in terms of secondary bacterial infections, also features in her study areas. Furthermore, she aims to contribute to innovations in Antibiotics applications in agriculture and livestock management. Belloumi’s work reflects a systemic view of Antibiotics as tools for both treatment and prevention. Her integrative research spans compound screening, in-vitro validation, and synergistic effect analysis—all focused on Antibiotics. Her long-term objective is to discover novel Antibiotics and formulate protocols that ensure their efficient, eco-friendly use. Ultimately, her passion for Antibiotics fuels all her academic and professional research directions.

Awards and Honors

Souhir Belloumi has earned multiple recognitions reflecting her advanced skills in biological sciences, especially her focus on Antibiotics. Through international workshops, scientific forums, and institutional programs, she has consistently been honored for her dedication to Antibiotics-based innovations. Her attendance at the GIZ Master-Class in Germany further refined her understanding of non-technical barriers to Antibiotics development. Certification in statistical analysis and QSE system management demonstrates her ability to evaluate Antibiotics efficacy using standardized methods. Her academic institutions have acknowledged her contributions through top-tier placements in Antibiotics research competitions and funding for student projects. Within the scope of her internships and professional contributions, her Antibiotics-centered projects often received commendations for originality and practical relevance. Whether analyzing essential oils or creating diagnostic kits, her methods aligned closely with Antibiotics mechanisms, leading to accolades from research supervisors and collaborators. Her scientific publications on the antibacterial efficacy of natural compounds also brought peer recognition in the Antibiotics research community. These honors validate her persistent commitment to advancing knowledge and technology in the Antibiotics domain. Belloumi’s record of achievements illustrates her prominence in Antibiotics research and the growing appreciation of her work by international networks and academic leaders.

Research Skills

Souhir Belloumi possesses a dynamic suite of research skills, with a prominent focus on Antibiotics. Her laboratory expertise includes molecular biology techniques such as DNA/RNA extraction and PCR—methods integral for studying Antibiotics interactions with pathogens. She is highly skilled in using LC-MS/MS and GC-MS for compound identification, especially when analyzing Antibiotics properties in bioactive substances. Her practical knowledge of biochemical assays helps determine the antioxidant and Antibiotics profiles of natural products. She applies food analysis techniques to measure the shelf-life extension properties of Antibiotics alternatives in meat preservation. In immunology, her proficiency with ELISA enhances her capacity to monitor the immune response affected by Antibiotics. Her background in virology and microbiology enables a deeper understanding of how Antibiotics modulate host-pathogen dynamics. Belloumi's statistical analysis capabilities support data-driven validation of Antibiotics efficacy. She uses software like GraphPad and Minitab for modeling Antibiotics inhibition curves and synergy tests. Furthermore, her scientific writing skill ensures the clear communication of complex Antibiotics results in academic publications. These diverse and advanced research competencies establish her as a reliable contributor to the field of Antibiotics. Her holistic application of these skills is instrumental in the ongoing development of Antibiotics therapies and resistance management.

Publication

Title: Combined essential oils as natural chicken meat preservatives: chemical composition, biological activities, synergy and shelf-life extension potential
Journal: Food Chemistry
Year: 2025

Conclusion

In conclusion, Souhir Belloumi represents a rising force in the field of biological sciences, with a career centered on the exploration and application of Antibiotics. Her academic training, research experiences, and scientific outputs all converge on the use of Antibiotics in modern health and environmental solutions. From natural compound identification to food safety innovations, her work integrates Antibiotics methodologies in meaningful ways. Her ability to link theory with practical implementation strengthens her standing in the Antibiotics research community. Belloumi's continued pursuit of excellence ensures her contributions to Antibiotics will remain impactful and progressive. Through laboratory precision, critical analysis, and interdisciplinary collaborations, she has built a profile deeply embedded in Antibiotics exploration. As she advances her career, her consistent focus on Antibiotics will no doubt lead to breakthroughs in resistance management, preservation technologies, and therapeutic innovations. Her publications and awards already reflect her influential presence in the Antibiotics landscape. In every project she undertakes, Antibiotics remain central—demonstrating her vision of science as a tool for health improvement and sustainable development. Therefore, her journey affirms the importance and future of Antibiotics in addressing global scientific challenges.

Anara Babayeva – Antibiotics – Best Researcher Award

Published on by Infectious

Anara Babayeva - Antibiotics - Best Researcher Award

Mugla Sıtkı Kocman University - Turkey

AUTHOR PROFILE 

GOOGLE SCHOLAR

EARLY ACADEMIC ROOTS 🌱

Anara Babayeva, born in Baku, Azerbaijan, on February 9, 1993, embarked on her academic journey with a passion for biology that would soon shape a compelling scientific career. After completing high school at A.S. Xalilov No. 263, she earned her bachelor's degree in biology from Azerbaijan State Pedagogical University. Her academic curiosity led her to Turkey, where she pursued and completed her master’s degree in biology at Muğla Sıtkı Koçman University. It was during this period that Anara began cultivating her deep scientific interest in molecular biology, microbiology, and the emerging field of functional genomics. The foundation she built during these formative years prepared her to engage in highly complex studies involving transcriptomics, metabolomics, and proteomics—fields crucial in the global fight against resistant bacteria. Even as a student, she was drawn to innovative research areas, especially the use of natural compounds and novel molecules like boron-derived antibiotics. Her early education served as a launchpad for numerous national and international research projects focused on bacterial gene expression, antimicrobial resistance, and metabolic profiling. Her work consistently demonstrated both a profound understanding of biological systems and a visionary approach toward leveraging antibiotics for therapeutic and diagnostic breakthroughs.

ADVANCED SCIENTIFIC EXPLORATIONS 🔬

At the graduate and post-graduate levels, Anara Babayeva immersed herself in the intricacies of biotechnology and molecular research. Her focus sharpened on developing novel methodologies to understand how antibiotics, particularly boron-containing compounds like epetraborole, interact with pathogenic strains such as Escherichia coli. At Muğla Sıtkı Koçman University, she became an active researcher in various TÜBİTAK and BAP-funded projects, contributing significantly to studies investigating bacterial gene responses, antimicrobial resistance, and phenolic compounds. Anara's efforts included advanced proteomic and transcriptomic analyses, often utilizing nano LC-MS/MS, 2D gel electrophoresis, and microarray platforms. Her expertise expanded through work on functional genomics, including KEIO mutant screening and ASKA clone analysis, highlighting her unique ability to decode complex genetic systems. Through these cutting-edge methods, Anara explored the biochemical and genomic impact of antibiotics on cellular networks. This phase of her career showcased not just technical proficiency but also a bold drive to innovate in diagnostics and treatment methodologies. Her work during this period not only contributed to scientific literature but also provided a deeper understanding of how natural compounds and synthetic antibiotics could serve as the cornerstone of next-generation antimicrobial strategies.

GROUNDBREAKING RESEARCH IN ANTIBIOTICS 🧪

Anara Babayeva’s scientific pursuits have consistently centered around the dynamic and urgent field of antibiotics research. Her hallmark contributions involve the investigation of epetraborole, a boron-containing experimental drug, and its mechanisms against bacterial strains. She has taken a leading role in several TÜBİTAK-funded projects examining how specific genes and proteins in Escherichia coli respond to antimicrobial stress, using technologies like NMR metabolomics and proteomics to detect subtle molecular changes. In particular, her research revealed novel gene targets and metabolic pathways affected by boron-based antibiotics, advancing our understanding of bacterial resistance and tolerance mechanisms. Through transcriptomic profiling, she has mapped how gene overexpression or deletion can modify bacterial behavior under drug pressure. These insights are essential in combating multidrug-resistant organisms, which pose a growing threat to global health. Anara’s ability to synthesize bioinformatics data with wet-lab experimentation has propelled her work to the forefront of functional antibiotic discovery. Her pioneering studies underscore how interdisciplinary approaches can unlock powerful antimicrobial solutions, turning theoretical findings into practical applications. By bridging molecular biology and clinical microbiology, she continues to redefine how antibiotics are conceptualized and tested in modern laboratories.

NATURAL COMPOUNDS AND ANTIMICROBIAL INNOVATION 🌿

In addition to synthetic antibiotics, Anara Babayeva has conducted extensive research on natural compounds with antimicrobial properties. Her investigations into Turkish propolis, phenolic acids, and even sea urchin extracts highlight her interest in exploring bioactive molecules from diverse ecosystems. She played key roles in studies examining the antimicrobial and anticancer effects of substances like Dracunculus vulgaris, Rosularia serrata, Amanita virosa, and Trichaptum biforme. These experiments often employed metabolomic profiling and transcriptomic studies to determine how natural extracts affect microbial survival, with findings suggesting that nature-derived compounds could complement traditional antibiotics or even pave the way for new drug classes. By examining how compounds such as propolis influence nucleic acid metabolism and protein expression in E. coli, Anara has contributed important data to the field of natural product pharmacology. Her research also sheds light on how bacteria develop resistance or tolerance to both synthetic and natural antimicrobial agents. This dual approach—studying both commercial antibiotics and bioactive compounds—illustrates her comprehensive understanding of microbial defense strategies and her commitment to uncovering sustainable, multifaceted antimicrobial therapies.

ACCOLADES AND ACADEMIC CONTRIBUTIONS 🏆

Throughout her career, Anara Babayeva has earned widespread recognition for her contributions to molecular biology and antibiotics research. Her scholarly work has been featured in respected journals such as Frontiers in Life Sciences and Related Technologies, Journal of Applied Microbiology, and International Journal of Peptide Research and Therapeutics. She has authored and co-authored impactful studies on epetraborole, bacterial gene responses, and antimicrobial resistance. Moreover, Anara has presented her findings at prominent international conferences, where her work on boron-based antibiotics, gene expression, and metabolomics has drawn praise from the academic community. Her participation in events such as the International Proteomics Congress and multiple TÜBİTAK conferences demonstrates her active engagement in scientific dialogue. Her reputation as an innovative and meticulous researcher has made her a respected figure in the antibiotic discovery field. Notably, her efforts are not limited to publication—she has been actively involved in mentoring, conducting experimental designs, and guiding younger researchers in the lab. These contributions ensure that her knowledge and passion for antibiotics continue to influence future scientific exploration and public health advancements.

SCIENTIFIC IMPACT AND GLOBAL REACH 🌍

Anara Babayeva’s research has transcended national boundaries, contributing valuable insights to the global scientific community’s understanding of antibiotics. Her interdisciplinary methodology—integrating genomics, proteomics, and metabolomics—has made significant strides in elucidating how bacteria interact with both synthetic and natural antimicrobial agents. By targeting genes associated with resistance and metabolic adaptation, she has helped pinpoint vulnerable molecular pathways, offering promising new targets for therapeutic development. Anara’s findings not only contribute to scientific journals but also inform broader discussions on antibiotic stewardship and resistance management worldwide. Her work is increasingly relevant in the age of rising antibiotic-resistant infections, especially as health organizations emphasize the need for next-generation antimicrobial drugs. Collaborations with international partners and participation in bilateral research projects further highlight her influence beyond Turkey and Azerbaijan. Her data on propolis and boron-derived antibiotics have implications for pharmaceutical development, bioengineering, and public health strategies. Anara’s science-driven advocacy promotes rational drug design and emphasizes a balance between innovation and sustainability in the use of antibiotics, making her a crucial voice in the global effort to protect the efficacy of life-saving antimicrobial therapies.

VISION FOR THE FUTURE OF ANTIBIOTICS RESEARCH 🔭

Looking ahead, Anara Babayeva envisions a future where advanced technologies converge to develop smarter, safer, and more sustainable antibiotics. Her ongoing research focuses on identifying novel gene-drug interactions, using tools like CRISPR screening, AI-driven bioinformatics, and NMR-based metabolomics. With a strong foundation in functional genomics and microbial systems biology, she aims to build integrated models that predict bacterial responses to emerging drug candidates. She is particularly interested in the synergy between synthetic molecules and natural extracts, which could minimize resistance development while enhancing drug efficacy. Future projects include studying microbial ecology under antimicrobial stress and developing biosensors for antibiotic susceptibility testing. Anara is also committed to mentoring a new generation of scientists who can carry forward the fight against antibiotic resistance. As antibiotics become an increasingly precious resource, her research will help redefine how they are developed, prescribed, and preserved. Her legacy is poised to be one of scientific rigor and visionary leadership—pioneering not just new compounds but also a paradigm shift in how the world understands and utilizes antibiotics for both human and environmental health.

NOTABLE PUBLICATION

  • Title: NMR metabolomics analysis of Escherichia coli cells treated with Turkish propolis water extract reveals nucleic acid metabolism as the major target
    Authors: ES Elgin, ŞS Çatav, A Babayeva, H Kim, E Dibek, B Çöl, YK Chae, ...
    Journal: Journal of Applied Microbiology

 

  • Title: Bor içeren bazı biyoaktif bileşikler
    Authors: E Dibek, A Babayeva, MS Kürkçü, NA Çöl, B Çöl
    Journal: Journal of Boron

 

  • Title: Genome-wide screen of Escherichia coli Keio mutant line identifies genes related to propolis effect
    Authors: E Dibek, A Babayeva, ES Elgin, MS Kürkçü, B Çöl
    Journal: European Food Research and Technology

 

  • Title: The Cytotoxic Effects of Turkish Bee Venom (Apis mellifera) on Selected Cancer Cell Lines
    Authors: A Babayeva, E Dibek, İ Kıvrak, B Çöl
    Journal: International Journal of Peptide Research and Therapeutics

 

  • Title: Genome-wide Screening of the Escherichia coli Keio Knockout Collection Identifies Genetic Determinants of Epetraborole Hypersusceptibility
    Authors: A Babayeva, B Çöl
    Journal: European Journal of Clinical Microbiology & Infectious Diseases

Charlene Pillay – Antibiotic – Best Researcher Award

Published on by Infectious

Charlene Pillay - Antibiotic - Best Researcher Award

Durban University of Technology - South Africa 

AUTHOR PROFILE

ORCID

🎓 EARLY ACADEMIC PURSUITS

Dr. Charlene Pillay’s academic journey began at the University of KwaZulu-Natal, where she pursued a passion for microbiology, culminating in a PhD in 2012. Her doctoral thesis focused on microbiologically influenced corrosion—an intersection of microbiology and material science—under the guidance of Professor Johnson Lin. This work explored the impact of nitrate sources on steel corrosion in simulated systems, laying a strong foundation for her future research interests. She earlier completed her MSc, BSc Honours, and BSc in Microbiology at the same institution. These academic milestones not only reflect her dedication but also shaped her into a specialist with deep-rooted scientific curiosity. Her early academic accomplishments were punctuated by significant research, blending microbiology with environmental and industrial applications. This robust educational background has since served as the bedrock of her teaching and research endeavors. Driven by curiosity and scholarly discipline, Dr. Pillay’s academic formation set the tone for a prolific scientific career.

👩‍🔬 PROFESSIONAL ENDEAVORS IN EDUCATION

Currently serving as a Senior Lecturer at Durban University of Technology (DUT), Dr. Charlene Pillay is deeply engaged in academic mentorship, curriculum development, and student supervision. Since 2015, she has delivered lectures, coordinated work-integrated learning, and facilitated essential industry-academic linkages. Her role extends beyond the classroom, involving the academic supervision of students placed in industrial settings, thus reinforcing experiential learning. Before joining DUT, she held various teaching and technical positions at the University of KwaZulu-Natal, including AdHoc Lecturer roles in Bacteriology and Advanced Bacteriology, and a stint as Laboratory Technician. These roles helped her develop both instructional expertise and technical skills crucial in laboratory education. Her teaching philosophy blends theory with hands-on experience, equipping students with a holistic understanding of microbiology. Through her academic contributions, she has established herself as a dynamic educator committed to nurturing future scientists and bridging academia with real-world applications in biosciences.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Pillay’s research focus reflects a unique synergy between microbiology, corrosion science, and ethnopharmacology. Initially concentrated on microbiologically influenced corrosion, her scholarly journey evolved to include antimicrobial research, bioremediation, and computational drug discovery using traditional medicinal plants. She has supervised numerous Honours and Master’s research projects addressing diverse topics such as bacterial modulation, type 2 diabetes therapy, soil bioremediation, and plant-based antimicrobial agents. Her publication portfolio spans high-impact journals like Archives of Microbiology, BMC Genomics, and Metabolites, showcasing work on quorum sensing modulators, gut microbiome studies, and therapeutic validation of plant-derived compounds. Notably, her interdisciplinary investigations bridge computational modeling with in vitro validations. Dr. Pillay’s research significantly contributes to understanding microbial behavior, the utility of plant secondary metabolites in health, and sustainable biomedical solutions. Her work remains rooted in addressing real-world health challenges through science-driven innovation, positioning her as a leading voice in applied microbiological research.

🏆 ACCOLADES AND RECOGNITION

Dr. Charlene Pillay’s scholarly excellence has earned her multiple accolades that underscore her research impact and scientific promise. She received the prestigious Ivan Oligvie Award from the Corrosion Institute of Southern Africa in 2008 for her early work in corrosion science. In 2009, she was honored with the SASM-Bio2Biz Travel Award, followed by a local conference travel award from the Faculty of Science and Agriculture at UKZN in 2011. These recognitions mark pivotal moments in her career, affirming the quality and relevance of her research. Beyond formal awards, her consistent publication record in reputable scientific outlets and active participation in interdisciplinary research teams further validate her professional standing. Through her collaborative work with colleagues like Professors Sabiu and Lin, Dr. Pillay continues to earn respect in both academic and applied science spheres. Her accolades reflect not only academic merit but also her growing influence as a respected contributor in microbiological and biomedical sciences.

🌿 IMPACT THROUGH SCIENTIFIC INNOVATION

Dr. Pillay's research has profound implications for environmental sustainability and public health, particularly through her investigations into plant-based therapeutics and microbial ecology. By integrating traditional medicinal knowledge with modern cheminformatics, she contributes to the discovery of bioactive compounds with the potential to combat non-communicable diseases like diabetes. Her studies on plant secondary metabolites, such as flavonoids and phenolic acids, are pivotal in developing alternative therapeutic strategies. Likewise, her research into bacterial biofilms and quorum sensing provides critical insights into managing antimicrobial resistance. The environmental aspect of her work—focusing on biodegradation of contaminants and soil microbiome dynamics—highlights her commitment to ecological well-being. These innovative approaches not only advance scientific understanding but also propose sustainable, low-cost healthcare and environmental solutions. Her work inspires future scientists to pursue research with tangible societal benefits, thereby enhancing her broader impact across academic, medical, and ecological domains.

👥 MENTORSHIP AND SCHOLARLY INFLUENCE

As a postgraduate supervisor, Dr. Charlene Pillay has significantly shaped the next generation of microbiologists and biomedical researchers. Her mentorship extends to BTech, Honours, and Master's students, with projects spanning from bioremediation techniques to computational drug modeling. She is known for encouraging innovation and critical thinking, guiding students through complex scientific methods and interdisciplinary topics. Many of her mentees have focused on real-world challenges such as antimicrobial resistance, plant-based drug development, and gut microbiome studies. Her mentorship fosters independence and scientific rigor, qualities evident in the student theses she has overseen. Through these scholarly interactions, she cultivates a research culture grounded in curiosity, integrity, and relevance. Her influence extends beyond academia into healthcare and biotechnology industries via her well-trained graduates. This legacy of mentorship underscores her dual role as both educator and enabler, investing in people as passionately as she invests in scientific exploration.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Charlene Pillay envisions a legacy rooted in transformative science and inclusive education. Her ambition to become a full professor with a thriving cohort of successful postgraduates reflects her long-term dedication to academic leadership. With aspirations to secure major research funding, she aims to expand her work in ethnopharmacology and microbial pathogenesis, focusing on groundbreaking, plant-based interventions for global health challenges. Her evolving research portfolio suggests forthcoming contributions in personalized medicine, antimicrobial strategies, and microbial genomics. As a thought leader in integrating traditional knowledge with modern science, she continues to set new standards for interdisciplinary research. Dr. Pillay’s legacy is one of innovation, mentorship, and impact—building bridges between past wisdom and future science. Her future contributions are poised to influence not only academia but also public health policy, environmental management, and scientific education, making her a pivotal figure in the global scientific community.

NOTABLE PUBLICATION

Title: A metagenomic investigation of the faecal RNA virome structure of asymptomatic chickens obtained from a commercial farm in Durban, KwaZulu-Natal province, South Africa
Authors: Nwokorogu, Vivian C.; Pillai, Santhosh; San, James E.; Pillay, Charlene; Nyaga, Martin M.; Sabiu, Saheed
Journal: BMC Genomics (2024)

Title: Cheminformatics Identification and Validation of Dipeptidyl Peptidase-IV Modulators from Shikimate Pathway-Derived Phenolic Acids towards Interventive Type-2 Diabetes Therapy
Authors: Balogun, Fatai Oladunni; Naidoo, Kaylene; Aribisala, Jamiu Olaseni; Pillay, Charlene; Sabiu, Saheed
Journal: Metabolites (2022)

Title: Identification of Flavonoid C-Glycosides as Promising Antidiabetics Targeting Protein Tyrosine Phosphatase 1B
Authors: Rampadarath, Athika; Balogun, Fatai Oladunni; Pillay, Charlene; Sabiu, Saheed
Journal: Journal of Diabetes Research (2022)

Title: Poultry gut health - microbiome functions, environmental impacts, microbiome engineering and advancements in characterization technologies
Authors: Aruwa, Christiana Eleojo; Pillay, Charlene; Nyaga, Martin M.; Sabiu, Saheed
Journal: Journal of Animal Science and Biotechnology (2021)

Title: The impact of additional nitrates in mild steel corrosion in a seawater/sediment system
Authors: Pillay, Charlene; Lin, Johnson
Journal: Corrosion Science (2014)